Jameson Davis
About Jameson
Jameson focuses his practice on the representation of public and private biotechnology, pharmaceutical and other life sciences companies with respect to a variety of intellectual property-based commercial transactions. He advises clients on license agreements, corporate partnerships, research and development collaborations, and manufacturing and supply agreements, as well as life sciences-related intellectual property matters within other corporate transactions, such as public offerings and mergers & acquisitions.
Experience
-
InnoCare Pharma and Zenas BioPharma Announce License Agreement
-
Valneva Announces up to $500 Million Debt Facility With Pharmakon Advisors
-
MannKind to Acquire scPharmaceuticals for up to $360 Million
-
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
-
Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma
Admissions and credentials
- California
- Massachusetts
- Not admitted to practice in Michigan
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.